跳至主要内容
临床试验/NCT04510337
NCT04510337已完成不适用

Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects the Depth of Blockade in Cancer Patients Undergoing Direct Laryngoscope Surgical Procedures

National Cancer Institute, Egypt1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年4月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Onset and duration of muscle relaxant

研究概览

简要总结

This study aim is to compare the effect of magnesium sulphate combined with low dose rocuronium versus standard dose rocuronium

详细描述

Comparing the effect of magnesium sulphate combined to low dose rocuronium versus standard dose rocuronium in cancer patients undergoing direct laryngoscopy for laryngeal tumors regarding intubating conditions, intraoperative relaxation, depth of anesthesia and recovery time.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Laryngeal tumors
  • Age 30-70 years

排除标准

  • Renal and or hepatic insufficiency
  • Neuromuscular disease
  • Large glottic and/or supra-glottic lesions with or without breathing difficulties
  • Known allergy to any of the used drug

研究组 & 干预措施

Standard rocuronium

Active Comparator

patients received rocuronium 0.6mg/kg

干预措施: standard rocuronium dose (Drug)

Magnesium

Experimental

patients received 100 ml saline with 50mg/kg magnesium sulphate infusion over 10 minutes

干预措施: Magnesium sulfate (Drug)

结局指标

主要结局

Onset and duration of muscle relaxant

时间窗: 90 minutes

Onset time of muscle relaxant and duration

次要结局

  • Degree of muscle relaxation(90 minutes)

研究者

发起方
National Cancer Institute, Egypt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Walaa Youssef Elsabeeny

Lecturer of anesthesia and pain management

National Cancer Institute, Egypt

研究点 (1)

Loading locations...

相似试验